Sign in
Taking people in United StatesNo phase

Home video exercise program for teenagers with congenital heart disease

Tests live online group exercise training in teenagers with congenital heart disease.

Key facts

Who runs it
Children's Mercy Hospital Kansas City
Where
Kansas City, United StatesSee the site
Trial code
Registry title
Remote Cardiac Rehab for Adolescents With Congenital Heart Disease
Status
Recruiting
People taking part
74 people, planned
Started
31 Aug 2023
Expected to end
Dec 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Remote Cardiac Rehabilitation
  • Active Control
Record updated
4 May 2026

Who can take part

The trial is looking for teenagers with one of three types of congenital heart disease who are cleared by their heart doctor to exercise. It tests home exercise sessions led live by video.

Age
12 to 19 years
Sex
All sexes
Disease stage
Congenital heart disease of one of three types: single-ventricle heart after Fontan surgery, Tetralogy of Fallot repaired with a transannular patch, or Dextro-transposition of the great arteries after arterial switch operation. People must reach maximal effort on a heart-lung exercise test (RER ≥1.1, or as judged by the exercise physiologist).
Earlier treatment
Must have had the surgery named for their heart type (Fontan palliation, transannular patch, or arterial switch operation). People taking milrinone cannot join.
Main reasons for not taking part
  • Height less than 132cm (4 ft 4 in), or unable to do moderate-to-vigorous exercise or the study tests
  • More than 15 MET-hours per week of organized sport or exercise over the past 12-months
  • Pregnancy, or planned surgery or procedure during the 12-week study
  • Serious heart problems, an implanted defibrillator, a rate-responsive pacemaker, a heart pump, or being on the heart transplant list
  • Poorly controlled asthma, or taking hormones for gender transition
Show the full registry criteria (22)Hide the full registry criteria

Who can take part

  • Age 12-19 years old
  • Male or Female
  • Diagnosed with one of three congenital heart diseases:; Univentricular heart with Fontan Palliation Tetralogy of Fallot with transannular patch Dextro-transposition of the great arteries with arterial switch operation
  • Primary Cardiology clearance for exercise participation
  • Internet access in their homes
  • Available for in-home exercise between 4-7pm on at least 3 days of the Monday-Friday work week
  • English Speaking
  • Achieving maximal effort on a cardiopulmonary exercise test, defined as RER ≥1.1 and/or in the judgement of the supervising exercise physiologist, a maximal effort was achieved but exercise capacity is limited by musculoskeletal deconditioning

Who cannot take part

  • Prescribed milrinone medication
  • Pregnancy or planned surgery or procedure (excluding outpatient, non-cardiac procedures) within the 12-week study period
  • Presence of significant cardiac dysfunction that would impair safe participation in moderate-to-vigorous intensity exercise
  • Listed for heart transplantation
  • Physically or developmentally unable to perform outcomes assessments or participate in moderate-to-vigorous intensity physical activity
  • Participating in > 15 MET-hours per week (mean weekly average over the past 12-months) of organized athletic/exercise activity (not including school physical education class)
  • Height less than 132cm
  • Meeting at least 1 exercise test safety or screening criteria on most recent exercise test (pre-study) or baseline outcomes visit exercise test
  • Significant changes baseline echocardiogram or most recent clinical echocardiogram (from past clinical echocardiogram) such as decrease in ventricular and/or valvar function, new obstruction, or any new structural abnormalities
  • Uncontrolled or poorly controlled asthma
  • Presence of implanted cardioverter-defibrillator
  • Pacemaker with rate-responsive function initiated
  • Reliance on ventricular assist device
  • Active engagement in hormone replacement for gender transition

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Congenital heart disease

This trial is currently available in United States.

  • Children's Mercy Kansas CityKansas City, United StatesContact: David A White, PhDTaking people

About the trial

What the trial wants to find out

The goal of this randomized controlled trial is to evaluate the effectiveness of video conferencing for the delivery of live-supervised, real-time cardiac rehabilitation (CR) exercise training to groups of adolescents with congenital heart disease (CHD) in their homes. Participants will be randomized to either the remote cardiac rehab (RCR) group or active control group. The RCR group will participate in live, group-based exercise training (3-5 participants per exercise session), in their homes 3 days per week for 45 minutes over 12-weeks. Exercise sessions will be led and supervised by a live health coach via telehealth video technology. The active control group will be provided informational handouts on health exercise for their cardiac diagnosis. The primary aim is to compare between group changes (0-12-weeks) in cardiorespiratory fitness (VO2peak). Secondary aims are to compare between group changes (0-12-weeks) in cardiac function (echocardiography), lean body mass, and physical frailty. Exploratory aims will compare between group changes (0-12-weeks) in physical function, quality of life, skeletal muscle function, and physical activity self-efficacy. Additionally, exploratory aims will explore the impact of demographic characteristics, program participation, program satisfaction, and daily physical activity on changes in cardiorespiratory fitness.

The 2 groups in the trial

  • Remote Cardiac RehabilitationTreatment being tested

    Following a 2-week ramp-up period, participants will attend group exercise sessions, remotely delivered in their homes, 3 days per week for 45-minutes over 12-weeks led by a live-interactive health coach. There are 4 exercise session types with different modalities: Session A: 75% aerobic, 25% resistance; Session B: 25% aerobic, 75% resistance; Session C: 50% aerobic, 50% resistance; and Session D: Exercise games (mix of modalities). Each participant will rotate through a 5-week set of exercise sessions (20 sessions) twice over the 10-weeks of group exercise period.

  • Active ControlExisting treatment, for comparison

    Participants will receive a handout describing physical activities appropriate for their congenital heart disease diagnosis and providing recommendations consistent with the physical activity recommendations for children and adolescents.

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Remotely Delivered Cardiac Rehabilitation for Adolescents With Congenital Heart Disease
Plain-language title
Home video exercise program for teenagers with congenital heart diseaseGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Criteria questions
Built from NCT06015191, who can take part
Record updated
4 May 2026